SCHEMBL32687507

SCHEMBL32687507

CCO[C@@H]1[C@@H](O)CN[C@@H]1Cc1ccc(-c2ccc3cnn(C)c3c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERCC1 P07992 1/20 0.40
▸ ERCC4 Q92889 1/20 0.40
▸ CYP2D6 P10635 3/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ SLC2A1 P11166 1/20 0.39
▸ CTSC P53634 2/20 0.38
▸ FASN P49327 1/20 0.37
▸ SYK P43405 2/20 0.34
▸ PDE1C Q14123 1/20 0.33
▸ SCD5 Q86SK9 1/20 0.33
▸ FLT3 P36888 1/20 0.33
▸ GSK3B P49841 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32687536 0.93 CYP2D6 (0.39) CYP2D6SMN1; SMN2LMNAMAPK1HIF1A
SCHEMBL32687276 0.83 CYP2D6 (0.42) CYP2D6SMN1; SMN2LMNAMAPK1HIF1A
SCHEMBL32687489 0.82 CYP2D6 (0.42) CYP2D6SMN1; SMN2LMNAMAPK1HIF1A
SCHEMBL32687222 0.82 BCHE (0.42) CYP2D6SMN1; SMN2LMNAMAPK1HIF1A
SCHEMBL32687150 0.81 CYP2D6 (0.40) CYP2D6SMN1; SMN2LMNAMAPK1HIF1A
SCHEMBL32687707 0.81 WNT1 (0.37) CYP2D6SMN1; SMN2LMNAMAPK1HIF1A
SCHEMBL32687035 0.81 CCNC (0.35) CTSCFASNSYKFLT3GSK3B
SCHEMBL32687373 0.81 CYP2D6 (0.39) CYP2D6SMN1; SMN2LMNAMAPK1HIF1A
SCHEMBL32686983 0.78 CYP2D6 (0.44) CYP2D6SMN1; SMN2LMNAMAPK1HIF1A
SCHEMBL32687709 0.78 CYP2D6 (0.44) CYP2D6SMN1; SMN2LMNAMAPK1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109696-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2026-04-23 — — US disclosed
US-20260078116-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078116-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, MCL1 ERCC1 3160/4885ERCC4 4381/4885CYP2D6 3364/4885
US-20260109696-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS KRAS, MYC, NRAS ERCC1 2570/4885ERCC4 3564/4885CYP2D6 2744/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback